Keyphrases
Reduced Mobility
100%
Patient Study
100%
Acutely Ill Patients
100%
Extended-duration Thromboprophylaxis
100%
Enoxaparin
75%
Once-daily
37%
Venous Thromboembolism
37%
Efficacy Endpoint
25%
Lower Extremity
12%
Placebo
12%
Infectious Diseases
12%
Hemorrhagic Complications
12%
Proximal Deep Vein Thrombosis
12%
Primary Safety
12%
Safety Endpoints
12%
Medical Conditions
12%
Respiratory Insufficiency
12%
Medical Patients
12%
Recurrent Venous Thromboembolism
12%
Causes of Mortality
12%
Ultrasonographic Examination
12%
Deep Vein
12%
Venous Thromboembolic Events
12%
Thromboprophylaxis
12%
Examination Protocol
12%
Optimal Duration
12%
Duration of Therapy
12%
Compression Ultrasonography
12%
Pharmacology, Toxicology and Pharmaceutical Science
Enoxaparin
100%
Venous Thromboembolism
83%
Respiratory Failure
16%
Placebo
16%
Deep Vein Thrombosis
16%
Diseases
16%